Trials / Conditions / WDHA Syndrome
WDHA Syndrome
3 registered clinical trials studyying WDHA Syndrome.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors NCT00131911 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors NCT00075439 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu NCT00004074 | National Cancer Institute (NCI) | Phase 1 |